Articles related to CORONARY ARTERY DISEASE (CAD)

A network meta-analysis of 24 trials (16,371 patients) found complete revascularization in myocardial infarction with multivessel disease reduced all-cause mortality by 15% compared to culprit-only revascularization, suggesting potential improved outcomes for this population.

The recent trial assessing CSL112’s role in enhancing cholesterol efflux capacity showed no significant reduction in cardiovascular events over one year among patients post-acute myocardial infarction, maintaining a safety profile consistent with placebo.

In a multinational study involving more than 1,500 patients with complex cardiac profiles, findings revealed no statistically significant difference in the primary outcome of death, myocardial infarction, or unplanned revascularization between FFR-guided complete revascularization and culprit-lesion-only PCI over nearly five years of follow-up.

With stress tests potentially costing the US healthcare system up to $500 million annually and leading to unwarranted procedures, it’s time to reassess their routine use in asymptomatic patients and consider more accurate diagnostic alternatives.

Leveraging artificial intelligence, the CathEF algorithm offers a groundbreaking method to assess heart function directly from angiogram videos, potentially reducing the need for invasive diagnostics and enhancing patient care strategies.

In a revealing case of myocardial bridging leading to cardiac arrest, coronary angiography and computed tomographic angiography played pivotal roles in diagnosis and surgical planning, highlighting the anomaly’s late-onset symptomatology in patients with existing cardiovascular conditions.